Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis [Phase 1]

View source ↗

Summary

A Phase 1 study is evaluating ASC50 tablets in healthy participants and individuals with plaque psoriasis to assess safety, tolerability, pharmacokinetics, phar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ASC50

Snippet

Sponsor: Ascletis Pharma (China) Co., Limited | Conditions: Plaque Psoriasis | Phase 1 | Status: RECRUITING